Efficacy and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease in China: a Multicenter, Single-Arm, Prospective, Observational Real-World Study
Latest Information Update: 22 Jan 2025
Price :
$35 *
At a glance
- Drugs Upadacitinib (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms EaseUpIBD
- 22 Jan 2025 New trial record